Skip to main content

Table 1 Relationship between miR-361-5p expression and clinicopathologic features of BC patients (n = 60)

From: MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1

variable Relative miR-361-5p expression P-value
  Low (n = 30) High (n = 30)  
Age    NS
 < 50 17 14  
 > 50 13 16  
Histological differentiation    NS
 Well 7 6  
 Moderate 14 17  
 Poor 9 7  
ER status    NS
 Positive 16 17  
 Negative 14 13  
PR status    NS
 Positive 21 14  
 Negative 9 16  
Her-2 status    NS
 Positive 11 8  
 Negative 19 22  
Tumor size    P < 0.05
 < 2 cm 11 21  
 2-5 cm 12 6  
 > 5 cm 7 3  
Lymph node metastasis    P < 0.01
 Yes 21 6  
 No 9 24  
Tumor stage    P < 0.05
 I 7 15  
 II 12 11  
 III 11 4  
Molecular subtype    NS
 Luminal like 16 17  
 HER-2 positive 10 7  
 Triple negative 4 6  
  1. Note: BC patients were divided into miR-361-5p High group and Low group according to the analysis of qRT-PCR detection. NS, not significant between different groups. Differences among variables were evaluated by χ2 or Fisher’s exact χ2 -test